PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
48.93%
5Y revenue/share CAGR at 75-90% of CX's 57.04%. Bill Ackman would encourage strategies to match competitor’s pace.
39.18%
3Y revenue/share CAGR similar to CX's 39.37%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
55.67%
Positive OCF/share growth while CX is negative. John Neff might see a comparative advantage in operational cash viability.
8.03%
3Y OCF/share CAGR 1.25-1.5x CX's 7.17%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
No Data
No Data available this quarter, please select a different quarter.
35.72%
Positive 5Y CAGR while CX is negative. John Neff might view this as a strong mid-term relative advantage.
95.54%
3Y net income/share CAGR above 1.5x CX's 22.62%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
68.15%
5Y equity/share CAGR above 1.5x CX's 17.49%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.82%
3Y equity/share CAGR above 1.5x CX's 19.25%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
109.02%
Dividend/share CAGR of 109.02% while CX is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
28.43%
Our short-term dividend growth is positive while CX cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.